Intestinal infections with Escherichia coli are a major cause of morbidity and mortality in
pigs. A distinctive variety of Shiga toxin-producing E. coli (STEC) is responsible for outbreaks of oedema disease (OD),
causing significant losses to the pig industry worldwide. Key virulence factors
of the causative strain include Shiga toxin 2e (Stx2e) and F18 colonisation
fimbriae which mediate STEC adherence to the small intestine. The genes
encoding F18 are organised in a single operon (fedABCEF). Our preliminary data show that FedR is a master
virulence-regulator that strongly upregulates the expression of the F18 operon
as well as its own expression. The high level of activation induced by FedR
suggests that inhibiting FedR will block F18-mediated colonisation and prevent
OD. In this project, we will screen a small compound library to identify
inhibitors that specifically target
FedR and assess the effect of these
compounds on colonisation and infection using our well-established in vitro and
in vivo systems. Identification of a synthetic antimicrobial that inhibits STEC
adherence to pig intestine will have a dual-benefit of alleviating the impact
of OD on the pig industry whilst addressing antibiotic resistance within
porcine STEC strains.